5DKN
Crystal Structure of Calcium-loaded S100B bound to SBi4225
5DKN の概要
| エントリーDOI | 10.2210/pdb5dkn/pdb |
| 関連するPDBエントリー | 5DKQ 5DKR |
| 分子名称 | Protein S100-B, CALCIUM ION, 2,2'-[heptane-1,7-diylbis(oxybenzene-4,1-diyl)]bis(1H-imidazole), ... (4 entities in total) |
| 機能のキーワード | malignant melanoma, calcium binding, covalent inhibitor, metal binding protein-inhibitor complex, metal binding protein/inhibitor |
| 由来する生物種 | Bos taurus (Bovine) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 11178.65 |
| 構造登録者 | Cavalier, M.C.,Ansari, M.I.,Pierce, A.D.,Wilder, P.T.,McKnight, L.E.,Raman, E.P.,Neau, D.B.,Bezawada, P.,Alasady, M.J.,Varney, K.M.,Toth, E.A.,MacKerell Jr., A.D.,Coop, A.,Weber, D.J. (登録日: 2015-09-03, 公開日: 2016-01-20, 最終更新日: 2023-09-27) |
| 主引用文献 | Cavalier, M.C.,Ansari, M.I.,Pierce, A.D.,Wilder, P.T.,McKnight, L.E.,Raman, E.P.,Neau, D.B.,Bezawada, P.,Alasady, M.J.,Charpentier, T.H.,Varney, K.M.,Toth, E.A.,MacKerell, A.D.,Coop, A.,Weber, D.J. Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations. J.Med.Chem., 59:592-608, 2016 Cited by PubMed Abstract: The drug pentamidine inhibits calcium-dependent complex formation with p53 ((Ca)S100B·p53) in malignant melanoma (MM) and restores p53 tumor suppressor activity in vivo. However, off-target effects associated with this drug were problematic in MM patients. Structure-activity relationship (SAR) studies were therefore completed here with 23 pentamidine analogues, and X-ray structures of (Ca)S100B·inhibitor complexes revealed that the C-terminus of S100B adopts two different conformations, with location of Phe87 and Phe88 being the distinguishing feature and termed the "FF-gate". For symmetric pentamidine analogues ((Ca)S100B·5a, (Ca)S100B·6b) a channel between sites 1 and 2 on S100B was occluded by residue Phe88, but for an asymmetric pentamidine analogue ((Ca)S100B·17), this same channel was open. The (Ca)S100B·17 structure illustrates, for the first time, a pentamidine analog capable of binding the "open" form of the "FF-gate" and provides a means to block all three "hot spots" on (Ca)S100B, which will impact next generation (Ca)S100B·p53 inhibitor design. PubMed: 26727270DOI: 10.1021/acs.jmedchem.5b01369 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.528 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






